Newborn Metabolic Screening for professionals
The Newborn Metabolic Screening Programme began in 1969. New Zealand was one of the first countries in the world to have this kind of programme.
Pātiki and Waharua Kōpito patterns
-
Guidelines, updates and practice reminders
Guidelines for practitioners providing services within the Newborn Metabolic Screening Programme in New Zealand February 2010. -
Procedures and practices
The Newborn Metabolic Screening Programme Policy Framework provides guidance for all programme providers within the screening programme. -
Informed consent
Obtaining informed consent for participation in the NMSP is central to best practice in maternity care. -
e-Learning module on blood spot collection
E-learning modules is to support best practice of blood spot collection available -
Newborn metabolic screening resources
Resources for heath practitioners for the newborn metabolic disorders programme. -
Newborn Metabolic Screening Programme FAQs
Answers to some commonly asked questions about the Newborn Metabolic Screening Programme -
Working together on quality improvements for newborn metabolic screening samples – Transit times
The Newborn Metabolic Screening Programme (NMSP) relies on timely testing and transit of samples to the laboratory for testing. -
Screening for severe combined immune deficiency
Frequently asked questions about severe combined immune deficiency (SCID) screening -
Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy (SMA) is a rare inherited neurogenetic condition which affects the motor nerves in the spinal cord (motor neurons).